ChemoCentryx Competitors and Similar CompaniesClear all
ChemoCentryx's competitors and similar companies include Turning Point Therapeutics.
 ChemoCentryx ChemoCentryx is a biopharmaceutical company commercializing and developing medications for inflammatory and autoimmune diseases and cancer. |  Turning Point Therapeutics Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases. | |
Founding Date | Founding Date 1997 | Founding Date 2013 |
Type | Type Subsidiary | Type Subsidiary |
Tags | ||
Locations | Locations San Carlos, US HQ | Locations San Diego, US HQ |
Employees | Employees 51 | Employees 474% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $32.2m (FY, 2021) | Revenue (est.) $30.8m (FY, 2021) |
Net income | Net income ($131.8m) (FY, 2021) | Net income ($236.6m) (FY, 2021) |
Funding | ||
Total funding raised | Total funding raised $ 149.5m | Total funding raised $ 144.4m |
For sources of this data, please see the company profile
View Company Profiles
Turning Point Therapeutics
HQ
San Diego, US
Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.
View company